Paper33465348
Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease.
Das L and 4 others. Am J Pathol, 2021. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease. Papers, record 33465348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33465348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dextran Sulfate | Major topic |
| Inflammation | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Animals | |
| Colitis | |
| Disease Models, Animal | |
| Immunity, Innate | |
| Low Density Lipoprotein Receptor-Related Protein-1 | |
| Mice, Inbred C57BL | |
| Toll-Like Receptors | |
| Mice |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL136395 | NHLBI NIH HHS | United States | R01HL136395 | PubMed and NIH |
Source NIH RePORTER
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6089198 | The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6089198 | PubMed |
| 2 | 4038613 | Catabolism of human tissue plasminogen activator in mice. | Blood | 1985 | https://conductscience.org/library/papers/4038613 | PubMed |
| 3 | 20440070 | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20440070 | PubMed |
| 4 | 26627550 | Immunopathogenesis of IBD: current state of the art. | Nat Rev Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/26627550 | PubMed |
| 5 | 11385576 | Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. | Nature | 2001 | https://conductscience.org/library/papers/11385576 | PubMed |
| 6 | 23543767 | Ly6 family proteins in neutrophil biology. | J Leukoc Biol | 2013 | https://conductscience.org/library/papers/23543767 | PubMed |
| 7 | 24560869 | The microbiome in inflammatory bowel disease: current status and the future ahead. | Gastroenterology | 2014 | https://conductscience.org/library/papers/24560869 | PubMed |
| 8 | 28144028 | Current and emerging therapeutic targets for IBD. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28144028 | PubMed |
| 9 | 24478370 | Tissue plasminogen activator contributes to alterations of neuronal migration and activity-dependent responses in fragile X mice. | J Neurosci | 2014 | https://conductscience.org/library/papers/24478370 | PubMed |
| 10 | 15883173 | The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. | J Exp Med | 2005 | https://conductscience.org/library/papers/15883173 | PubMed |
| 11 | 8350599 | Clinicopathologic study of dextran sulfate sodium experimental murine colitis. | Lab Invest | 1993 | https://conductscience.org/library/papers/8350599 | PubMed |
| 12 | 31848365 | Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury. | Sci Rep | 2019 | https://conductscience.org/library/papers/31848365 | PubMed |
| 13 | 26000334 | Experimental Models of Inflammatory Bowel Diseases. | Cell Mol Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/26000334 | PubMed |
| 14 | 27338838 | Physiological Roles of Non-Neuronal NMDA Receptors. | Trends Pharmacol Sci | 2016 | https://conductscience.org/library/papers/27338838 | PubMed |
| 15 | 1534242 | The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. | Annu Rev Immunol | 1992 | https://conductscience.org/library/papers/1534242 | PubMed |
| 16 | 28129537 | The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier. | Cell | 2017 | https://conductscience.org/library/papers/28129537 | PubMed |
| 17 | 24129569 | LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein. | J Biol Chem | 2013 | https://conductscience.org/library/papers/24129569 | PubMed |
| 18 | 10703776 | Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. | JAMA | 2000 | https://conductscience.org/library/papers/10703776 | PubMed |
| 19 | 27366227 | The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. | Ther Adv Gastroenterol | 2016 | https://conductscience.org/library/papers/27366227 | PubMed |
| 20 | 3097031 | Structure and function of human tissue-type plasminogen activator (t-PA). | J Cell Biochem | 1986 | https://conductscience.org/library/papers/3097031 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42393407 | Pre-Treatment with Estradiol, But not Progesterone, Exacerbates DSS Colitis: Dysregulated Innate Immunity and Impaired Epithelial Damage Response. | Inflammation | 2026 | https://conductscience.org/library/papers/42393407 | PubMed |
| 37368488 | An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein. | JCI Insight | 2023 | https://conductscience.org/library/papers/37368488 | PubMed |
| 36947703 | An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages. | J Cell Biochem | 2023 | https://conductscience.org/library/papers/36947703 | PubMed |
| 36266319 | The LRP1/CD91 ligands, tissue-type plasminogen activator, α2-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling. | Sci Rep | 2022 | https://conductscience.org/library/papers/36266319 | PubMed |
| 34888951 | α1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain. | FASEB J | 2022 | https://conductscience.org/library/papers/34888951 | PubMed |
| 34810220 | A Soluble PrPC Derivative and Membrane-Anchored PrPC in Extracellular Vesicles Attenuate Innate Immunity by Engaging the NMDA-R/LRP1 Receptor Complex. | J Immunol | 2022 | https://conductscience.org/library/papers/34810220 | PubMed |
| 34406905 | Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation. | Am J Physiol Cell Physiol | 2021 | https://conductscience.org/library/papers/34406905 | PubMed |
| 33810275 | Fibrinolysis: A Primordial System Linked to the Immune Response. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33810275 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33465348
GET https://conductscience.org/api/papers/v1/33465348/references?page=2